RhumbLine Advisers
OPTR

RhumbLine Advisers’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

RhumbLine Advisers’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-49,175
Closed -$620K – 3055
2013
Q3 		$620K Buy
49,175
+753
+2% +$9.98K ﹤0.01% 2080
2013
Q2 		$701K Buy
+48,422
New +$705K ﹤0.01% 2009

RhumbLine Advisers's OPTR Position: Q4 2013 in Review

RhumbLine Advisers sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 49,175 shares — an estimated $620K sold.

RhumbLine Advisers first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $701K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • RhumbLine Advisers reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • RhumbLine Advisers sold 49,175 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $620K.
  • RhumbLine Advisers first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • RhumbLine Advisers's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $701K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on RhumbLine Advisers's 13F filing for Q4 2013, filed 3 Feb 2014.